ISSN 2146-832X
 

Original Research 


Chronic Subclinical Inflammation in Middle Aged Bangladeshi Population: Association with Low High-density Lipoprotein Cholesterol

Mohammad Abdul Hai Siddique, Muhammad Saiedullah, Matiar Rahman, Liaquat Ali, Mohammad Amirul Islam.

Abstract
Aim: The present study was undertaken to investigate the association of chronic subclinical inflammation as assessed by high sensitivity C-reactive protein (hsCRP) with high-density lipoprotein (HDL) cholesterol in a middle aged Bangladeshi population.
Materials and Methods: Total 348 adults (169 male, 179 female) were included and anthropometric data and clinical histories were recorded. Serum lipids were measured by enzymatic endpoint technique and hsCRP was estimated by immunoturbidimetric method.
Results: The mean of age and body mass index (BMI) of the total subjects were 50.5 ± 11.5 years and 26.7 ± 4.5 kg/m2 respectively. Substantial proportions (57.47%) of the subjects had low HDL cholesterol. Of the total subjects, 45.4% had hsCRP > 3.0 mg/l followed by 31.9% with hsCRP: 1.0-3.0 mg/l coupled with elevation of one or more traditional risk factors of CVDs. Lipid parameters showed no significant difference between subjects with low and moderate (hsCRP ≤3.0 mg/l) and high hsCRP (hsCRP > 3.0 mg/l). But BMI was significantly higher in high hsCRP group compared to low hsCRP group [25.4 (23.3-27.9) vs 27.3 (24.3-30.1) kg/m2, p<0.0001)]. Compared to male, female had higher hsCRP [4.0 (1.9-7.6) mg/l vs 1.7 (0.84-3.9) mg/l, p<0.0001)]. Spearman’s test and multiple regression analysis showed no significant (p>0.05) relationship of hsCRP with lipid parameters. But, when adjusted for age, sex, BMI and glycemic status, significant negative association for hsCRP was observed with HDL cholesterol (β= -0.1654, p= 0.0139).
Conclusion: This data indicated that chronic subclinical inflammation is associated with low HDL cholesterol in middle aged Bangladeshi population.

Key words: Chronic subclinical inflammation, High sensitivity C-reactive protein, Lipoprotein-lipid profile, HDL cholesterol


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mohammad Abdul Hai Siddique
Articles by Muhammad Saiedullah
Articles by Matiar Rahman
Articles by Liaquat Ali
Articles by Mohammad Amirul Islam
on Google
on Google Scholar
Article Statistics
 Viewed: 1677
Downloaded: 384
Cited: 0


REFERENCES
1. Mendis S, Puska P, Norrving B. Global Atlas on cardiovascular disease prevention and control. In: World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization, 2011. http://www.who.int/cardiovascular_diseases/publications/ atlas_cvd/en/ (Accessed 24 September 2016).
2. Joint WHO/FAO Expert Consultation on Diet Nutrition and the Prevention of Chronic Diseases and World Health Organization Department of Nutrition for Health and Development. In: WHO technical report series; Diet, nutrition and the prevention of chronic diseases: Report of a joint WHO/FAO expert consultation; Geneva: World Health Organization; 2003. http://www.who.int/dietphysicalactivity/publications/trs916/en/ (Accessed 24 September 2016).
3. Sassi F, Cecchini M, Lauer J, Chisholm D. Improving lifestyles, tackling obesity: The health and economic impact of prevention strategies, 2009. http://dx.doi.org/10.1787/220087432153 https://doi.org/10.1787/220087432153
4. Popko K, Gorska E, Stelmaszczyk-Emmel A, Plywaczewski R, Stoklosa A, Gorecka D, Pyrzak B, Demkow U. Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res 2010;15:120-2.
5. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999;22:1971-7.
6. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C reactive protein levels in overweight and obese adults (Comments). J Am Med Assoc 1999; 282:2131-5. https://doi.org/10.1001/jama.282.22.2131
7. Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC, Hofman A, Witteman JC. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler ThrombVasc Biol 1999;19:1986-91. https://doi.org/10.1161/01.ATV.19.8.1986
8. Kopp HP, Krzyzanowska K, Möhlig M, Spranger J, Pfeifferand AF, Schernthaner G. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) 2005;29:766-71. https://doi.org/10.1038/sj.ijo.0802983 [Pubmed]   
9. Pfutzner A, Forst T. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther 2006;8:28-36. https://doi.org/10.1089/dia.2006.8.28 [Pubmed]   
10.Grufman H, Goncalves I, Edsfeldt A, Nitulescu M, Persson A, Nilsson M, Nilsson J. Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques. J Intern Med 2014;275:127-33. https://doi.org/10.1111/joim.12133 [Pubmed]   
11.Brooks GC, Blaha MJ, Blumenthal RS. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol 2010;106:56-61. https://doi.org/10.1016/j.amjcard.2010.02.017 [Pubmed]   
12.Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959 -65. https://doi.org/10.1056/NEJM200106283442601 [Pubmed]   
13.The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 2002;106:3143-421.
14.Schaefer EJ. Lipoproteins, nutrition, and heart disease. Am J Clin Nutr 2002;75:191-212.
15.Yusuf PS, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-52. https://doi.org/10.1016/S0140-6736(04)17018-9
16.Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease—six year follow-up experience. The Framingham Study. Ann Intern Med 1961;55:33-50. https://doi.org/10.7326/0003-4819-55-1-33 [Pubmed]   
17.Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann Intern Med1971;74:1-12.
18.Gotto AM Jr. Evolving concepts of dyslipidemia, atherosclerosis, and cardiovascular disease: The Louis F. Bishop lecture. J Am Coll Cardiol 2005;46:1219-24.
19.Tehrani DM, Gardin JM, Yanez D, Hirsch CH, Lloyd-Jones DM, Stein PK, Wong ND. Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular health study. Atherosclerosis 2013; 231:246-51. https://doi.org/10.1016/j.atherosclerosis.2013.08.036 [Pubmed]    [PMC Free Fulltext]   
20.Chrysohoou C, Pitsavos C, Skoumas J, Masoura C, Katinioti A, Panagiotakos D, Stefanadis C. The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study. Int J Cardiol 2007;122:29-33. https://doi.org/10.1016/j.ijcard.2006.11.010 [Pubmed]   
21. Ghuge GD, Zine R, Mogrekar MR. High sensitivity C-reactive protein, paraoxonase 1 and high density lipoprotein cholesterol in myocardial infarction. International Journal of Biomedical and Advance Research 2012;03:637-9. http://dx.doi.org/10.7439/ijbar.v3i8.693 https://doi.org/10.7439/ijbar.v3i8.693
22.Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460-70. https://doi.org/10.1161/01.CIR.88.5.2460 [Pubmed]   
23.World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. 2006. http://www.who.int/diabetes/publications/ diagnosis_diabetes2006/en/ (Accessed 24 September 2016).
24.Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
25.Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511. https://doi.org/10.1161/01.CIR.0000052939.59093.45
26.Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patient with average cholesterol levels. Cholesterol and recurrent events trail investigators. New J Med 1996;335:1001-9. https://doi.org/10.1056/NEJM199610033351401 [Pubmed]   
27.Verschuren WM, Jacob DR, Blomberg BPM, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Nedelijkovic S, Nissinen A, Toshima H. Serum cholesterol and long term coronary disease mortality in different cultures: 25 years follow up of seven countries study. J Am Med Assoc 1995;274:131-6. https://doi.org/10.1001/jama.1995.03530020049031
28.National Cholesterol Education Program (NCEP). Second report of the expert panel and detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:4333-445.
29.Thakur S, Gupta S, Parchwani H, Shah V, Yadav V. Hs-CRP - A Potential Marker for Coronary Heart Disease. Indian Journal of Fundamental and Applied Life Sciences 2011;1:1-4. http://www.cibtech.org/ IJFALS_Vol.1.Issue1.htm (Accessed 24 September 2016).
30.Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. https://doi.org/10.1161/01.CIR.0000053730.47739.3C [Pubmed]   
31.Shindhu S, Singh HK, Salman MT, Fatima J, Verma VK. Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients. J Pharmacol Pharmacother 2011;2:261-5. https://doi.org/10.4103/0976-500X.85954 [Pubmed]    [PMC Free Fulltext]   
32.Majka DS, Chang RW, Vu TH, Palmas W, Geffken DF, Ouyang P, Ni H, Liu K. Physical activity and high-sensitivity C - reactive protein: the multi-ethnic study of atherosclerosis. Am J Prev Med. 2009; 36: 56-62. https://doi.org/10.1016/j.amepre.2008.09.031 [Pubmed]    [PMC Free Fulltext]   
33.Rehnuma B, Hassan Z, Ibrahim M, Ali L. Serum levels of high sensitivity C-reactive protein and its association with lipidemic status in Bangladeshi healthy adults. Journal of Pathology of Nepal 2014;4:644-8. https://doi.org/10.3126/jpn.v4i8.11591
34.Ferdousi F, Siddique MAH, Kamaluddin SM, Saiedullah M, Ali L. Association of lipid abnormalities with high-sensitivity C-reactive protein in patients treated with atorvastatin. J Diab Metab 2015;6:564. https://doi.org/10.4172/2155-6156.1000564
35.Sampietro T, Bigazzi F, Dal PB, Fusaro S, Greco F, Tuoni M, Bionda A. Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammatory condition? Circulation 2002;105:11-4.
36.Zuliani G, Volpato S, Ble A, Bandinelli S, Corsi AM, Lauretani F, Paolisso G, Fellin R, Ferrucci L. High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study. Atherosclerosis 2007;192:384-90. https://doi.org/10.1016/j.atherosclerosis.2006.05.024 [Pubmed]    [PMC Free Fulltext]   
37.Wan Ahmad WN, Sakri F, Mokhsin A, Rahman T, Mohd Nasir N, AbdulRazak S, Md Yasin M, Mohd Ismail A, Ismail Z, Nawawi H. Low serum high density lipoprotein cholesterol concentration is an independent predictor for enhanced inflammation and endothelial activation. PLoS One 2015;23;10:e0116867. [DOI via Crossref]    https://doi.org/10.1371/journal.pone.0116867
38.Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC. HighDensity Lipoprotein Function. J Am Coll Cardiol 2005;46:1792-8. https://doi.org/10.1016/j.jacc.2005.06.080 [Pubmed]   
39.Ansell BJ, Fonarow GC and Fogelman AM . The paradox of dysfunctional high-density lipoprotein. Current Opinion in Lipidology 2007;18:427-34. https://doi.org/10.1097/MOL.0b013e3282364a17 [Pubmed]   
40.Patel S, Puranik R, Nakhla S, Lundman P, Stocker R, Wang XS, Lambert G, Rye KA, Barter PJ, Nicholls SJ, Celermajer DS. Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis 2009;204:424-8. https://doi.org/10.1016/j.atherosclerosis.2008.07.047 [Pubmed]   

How to Cite this Article
Pubmed Style

Mohammad Abdul Hai Siddique, Muhammad Saiedullah, Matiar Rahman, Liaquat Ali, Mohammad Amirul Islam. Chronic Subclinical Inflammation in Middle Aged Bangladeshi Population: Association with Low High-density Lipoprotein Cholesterol. J Mol Pathophysiol. 2016; 5(4): 73-78. doi:10.5455/jmp.20161024100426


Web Style

Mohammad Abdul Hai Siddique, Muhammad Saiedullah, Matiar Rahman, Liaquat Ali, Mohammad Amirul Islam. Chronic Subclinical Inflammation in Middle Aged Bangladeshi Population: Association with Low High-density Lipoprotein Cholesterol. http://www.jmolpat.com/?mno=242795 [Access: May 21, 2019]. doi:10.5455/jmp.20161024100426


AMA (American Medical Association) Style

Mohammad Abdul Hai Siddique, Muhammad Saiedullah, Matiar Rahman, Liaquat Ali, Mohammad Amirul Islam. Chronic Subclinical Inflammation in Middle Aged Bangladeshi Population: Association with Low High-density Lipoprotein Cholesterol. J Mol Pathophysiol. 2016; 5(4): 73-78. doi:10.5455/jmp.20161024100426



Vancouver/ICMJE Style

Mohammad Abdul Hai Siddique, Muhammad Saiedullah, Matiar Rahman, Liaquat Ali, Mohammad Amirul Islam. Chronic Subclinical Inflammation in Middle Aged Bangladeshi Population: Association with Low High-density Lipoprotein Cholesterol. J Mol Pathophysiol. (2016), [cited May 21, 2019]; 5(4): 73-78. doi:10.5455/jmp.20161024100426



Harvard Style

Mohammad Abdul Hai Siddique, Muhammad Saiedullah, Matiar Rahman, Liaquat Ali, Mohammad Amirul Islam (2016) Chronic Subclinical Inflammation in Middle Aged Bangladeshi Population: Association with Low High-density Lipoprotein Cholesterol. J Mol Pathophysiol, 5 (4), 73-78. doi:10.5455/jmp.20161024100426



Turabian Style

Mohammad Abdul Hai Siddique, Muhammad Saiedullah, Matiar Rahman, Liaquat Ali, Mohammad Amirul Islam. 2016. Chronic Subclinical Inflammation in Middle Aged Bangladeshi Population: Association with Low High-density Lipoprotein Cholesterol. Journal of Molecular Pathophysiology, 5 (4), 73-78. doi:10.5455/jmp.20161024100426



Chicago Style

Mohammad Abdul Hai Siddique, Muhammad Saiedullah, Matiar Rahman, Liaquat Ali, Mohammad Amirul Islam. "Chronic Subclinical Inflammation in Middle Aged Bangladeshi Population: Association with Low High-density Lipoprotein Cholesterol." Journal of Molecular Pathophysiology 5 (2016), 73-78. doi:10.5455/jmp.20161024100426



MLA (The Modern Language Association) Style

Mohammad Abdul Hai Siddique, Muhammad Saiedullah, Matiar Rahman, Liaquat Ali, Mohammad Amirul Islam. "Chronic Subclinical Inflammation in Middle Aged Bangladeshi Population: Association with Low High-density Lipoprotein Cholesterol." Journal of Molecular Pathophysiology 5.4 (2016), 73-78. Print. doi:10.5455/jmp.20161024100426



APA (American Psychological Association) Style

Mohammad Abdul Hai Siddique, Muhammad Saiedullah, Matiar Rahman, Liaquat Ali, Mohammad Amirul Islam (2016) Chronic Subclinical Inflammation in Middle Aged Bangladeshi Population: Association with Low High-density Lipoprotein Cholesterol. Journal of Molecular Pathophysiology, 5 (4), 73-78. doi:10.5455/jmp.20161024100426





Most Viewed Articles
  • Prevention and treatment of cyclophosphamide and ifosfamide-induced hemorrhagic cystitis
    Ertan Altaylı, Ercan Malkoc, Bilal Fırat Alp, Ahmet Korkmaz
    J Mol Pathophysiol. 2012; 1(1): 53-62
    » Abstract & References » doi: 10.5455/jmp.20120321060902

  • Therapeutic potential of metals in managing diabetes mellitus: a review
    Geeta Pandey, Gyan Chand Jain, Nidhi Mathur
    J Mol Pathophysiol. 2012; 1(1): 63-76
    » Abstract & References » doi: 10.5455/jmp.20120410105457

  • Modulation of glucose and lipid metabolism in adrenalectomised rats given glycyrrhizic acid
    Yan Qi Ng, Chanchal Chandramouli, So Ha Ton, Khalid Abdul Kadir, Fahreen Haque, Melissa Sharmini Tamotharan
    J Mol Pathophysiol. 2012; 1(1): 3-20
    » Abstract & References » doi: 10.5455/jmp.20120221113254

  • Oxidative stress in acne vulgaris: an important therapeutic target
    Ahmed Salih Sahib, Haidar Hamid Al-Anbari, Ahmed R. Abu Raghif
    J Mol Pathophysiol. 2013; 2(1): 27-31
    » Abstract & References » doi: 10.5455/jmp.20130127102901

  • Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated
    Nicholas P Booth, Wells Brockbank, Samuel Oh, Karl Kingsley
    J Mol Pathophysiol. 2012; 1(1): 29-36
    » Abstract & References » doi: 10.5455/jmp.20120609040915

  • Cytotoxic effects of conjugated linoleic acids on human hepatoma cancer cells (HepG2)
    Achenef Melaku, Arifah Abdul Kadir, Fauziah Othman, Goh Yong Meng, Awis Qurni Sazili
    J Mol Pathophysiol. 2012; 1(1): 43-48
    » Abstract & References » doi: 10.5455/jmp.20120127120302

  • Role of intracellular adhesion molecules-1 (ICAM-1) in the pathogenesis of toxoplasmic retinochoroiditis
    Nagwa Mostafa El-Sayed, Khadiga Ahmed Ismail
    J Mol Pathophysiol. 2012; 1(1): 37-42
    » Abstract & References » doi: 10.5455/jmp.20120307042400

  • Periodontitis as a risk factor for cardiovascular disease with its treatment modalities: a review
    Amit Bhardwaj, Shalu V. Bhardwaj
    J Mol Pathophysiol. 2012; 1(1): 77-83
    » Abstract & References » doi: 10.5455/jmp.20120206034643

  • A new hope in biomedical research area; Journal of Molecular Pathophysiology
    Ahmet Korkmaz, Turgut Topal
    J Mol Pathophysiol. 2012; 1(1): 1-2
    » Abstract & References » doi: 10.5455/jmp.20120604123051

  • Arterial stiffness and inflammation in patients on hemodialysis
    Vaia D. Raikou, Despina Kyriaki, John N. Boletis
    J Mol Pathophysiol. 2012; 1(1): 21-28
    » Abstract & References » doi: 10.5455/jmp.20120530044656

  • Most Downloaded
  • Prevention and treatment of cyclophosphamide and ifosfamide-induced hemorrhagic cystitis
    Ertan Altaylı, Ercan Malkoc, Bilal Fırat Alp, Ahmet Korkmaz
    J Mol Pathophysiol. 2012; 1(1): 53-62
    » Abstract & References » doi: 10.5455/jmp.20120321060902

  • Antioxidant effects of astaxanthin in various diseases—a review
    Lawson Ekpe, Kenneth Inaku, Victor Ekpe
    J Mol Pathophysiol. 2018; 7(1): 1-6
    » Abstract » doi: 10.5455/jmp.20180627120817

  • Effects of Prolonged Fasting on Sperm Count
    Seriki A Samuel, Adebayo O Francis, Atsukwei Denen, Odetola O Anthony
    J Mol Pathophysiol. 2015; 4(3): 99-102
    » Abstract & References » doi: 10.5455/jmp.20150915011928

  • Oxidative stress in acne vulgaris: an important therapeutic target
    Ahmed Salih Sahib, Haidar Hamid Al-Anbari, Ahmed R. Abu Raghif
    J Mol Pathophysiol. 2013; 2(1): 27-31
    » Abstract & References » doi: 10.5455/jmp.20130127102901

  • Therapeutic potential of metals in managing diabetes mellitus: a review
    Geeta Pandey, Gyan Chand Jain, Nidhi Mathur
    J Mol Pathophysiol. 2012; 1(1): 63-76
    » Abstract & References » doi: 10.5455/jmp.20120410105457

  • A new hope in biomedical research area; Journal of Molecular Pathophysiology
    Ahmet Korkmaz, Turgut Topal
    J Mol Pathophysiol. 2012; 1(1): 1-2
    » Abstract & References » doi: 10.5455/jmp.20120604123051

  • Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated
    Nicholas P Booth, Wells Brockbank, Samuel Oh, Karl Kingsley
    J Mol Pathophysiol. 2012; 1(1): 29-36
    » Abstract & References » doi: 10.5455/jmp.20120609040915

  • Acute Acalculous Cholecystitis Due to Salmonella Typhi: A Case of 12 Years Old Child
    Bassem Abou Merhi, Nabil Daoud, Aya Assaf, Raymond Kamel, Mariam Rajab
    J Mol Pathophysiol. 2014; 3(1): 20-22
    » Abstract & References » doi: 10.5455/jmp.20131216011207

  • Cytotoxic effects of conjugated linoleic acids on human hepatoma cancer cells (HepG2)
    Achenef Melaku, Arifah Abdul Kadir, Fauziah Othman, Goh Yong Meng, Awis Qurni Sazili
    J Mol Pathophysiol. 2012; 1(1): 43-48
    » Abstract & References » doi: 10.5455/jmp.20120127120302

  • The chemical composition and pharmacological activities of geopropolis produced by Melipona fasciculata Smith in northeast Brazil
    MARIA ARAUJO, MICHELLE BUFALO, BRUNO CONTI, ARY FERNANDES JR., BORYANA TRUSHEVA, VASSYA BANKOVA, JOSE SFORCIN
    J Mol Pathophysiol. 2015; 4(1): 12-20
    » Abstract & References » doi: 10.5455/jmp.20150204115607

  • Most Cited Articles
  • The chemical composition and pharmacological activities of geopropolis produced by Melipona fasciculata Smith in northeast Brazil
    MARIA ARAUJO, MICHELLE BUFALO, BRUNO CONTI, ARY FERNANDES JR., BORYANA TRUSHEVA, VASSYA BANKOVA, JOSE SFORCIN
    J Mol Pathophysiol. 2015; 4(1): 12-20
    » Abstract & References » doi: 10.5455/jmp.20150204115607
    Cited : 13 times [Click to see citing articles]

  • Importance of HSP70 in Livestock - at cellular level
    SMRUTI RANJAN MISHRA, TAPAN KUMAR PALAI
    J Mol Pathophysiol. 2014; 3(2): 30-32
    » Abstract & References » doi: 10.5455/jmp.20141028023220
    Cited : 8 times [Click to see citing articles]

  • Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing
    Florian T Unger, Susanne Bentz, Jana Krüger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprüssel, Hartmut Juhl, Kerstin A David
    J Mol Pathophysiol. 2015; 4(3): 108-121
    » Abstract & References » doi: 10.5455/jmp.20151023055556
    Cited : 7 times [Click to see citing articles]

  • Consumption of a High-Fat Breakfast on Consecutive Days Alters the Area-under-the-curve for Selected CVD Biomarkers
    Brian K McFarlin, Katie C Carpenter, Adam S Venable, Eric A Prado, Andie L Henning
    J Mol Pathophysiol. 2015; 4(1): 6-11
    » Abstract & References » doi: 10.5455/jmp.20150127045909
    Cited : 6 times [Click to see citing articles]

  • Therapeutic potential of metals in managing diabetes mellitus: a review
    Geeta Pandey, Gyan Chand Jain, Nidhi Mathur
    J Mol Pathophysiol. 2012; 1(1): 63-76
    » Abstract & References » doi: 10.5455/jmp.20120410105457
    Cited : 5 times [Click to see citing articles]

  • Prevention and treatment of cyclophosphamide and ifosfamide-induced hemorrhagic cystitis
    Ertan Altaylı, Ercan Malkoc, Bilal Fırat Alp, Ahmet Korkmaz
    J Mol Pathophysiol. 2012; 1(1): 53-62
    » Abstract & References » doi: 10.5455/jmp.20120321060902
    Cited : 5 times [Click to see citing articles]

  • The effect of ethanol extract of Nigerian ficus glumosa leaf on liver function in Diabetic rats
    Umar Zayyanu Usman, Mahaneem Binti Mohamed
    J Mol Pathophysiol. 2015; 4(3): 103-107
    » Abstract & References » doi: 10.5455/jmp.20151022125106
    Cited : 4 times [Click to see citing articles]

  • Proximate and vitamin C analysis of wild edible plants consumed by Bodos of Assam, India
    Hwiyang Narzary1, Ananta Swargiary2 and Sanjay Basumatary3*
    J Mol Pathophysiol. 2015; 4(4): 128-133
    » Abstract & References » doi: 10.5455/jmp.20151111030040
    Cited : 4 times [Click to see citing articles]

  • Oxidative stress in acne vulgaris: an important therapeutic target
    Ahmed Salih Sahib, Haidar Hamid Al-Anbari, Ahmed R. Abu Raghif
    J Mol Pathophysiol. 2013; 2(1): 27-31
    » Abstract & References » doi: 10.5455/jmp.20130127102901
    Cited : 3 times [Click to see citing articles]

  • Disulfiram Neurotoxicity: Decrements in Ethanolamine, Serine, and Inositol Glycerophospholipids.
    Paul L Wood, Ryan S Alexander, Cameron C Felty
    J Mol Pathophysiol. 2014; 3(3): 33-37
    » Abstract & References » doi: 10.5455/jmp.20141122032817
    Cited : 2 times [Click to see citing articles]